Skip to content

Medpace Holdings, Inc. MEDP Other — Total Revenue

Other product segments

Oncology
$237.56M+60.5%
Metabolic
$201.24M+18.0%
Cardiology
$80.21M+46.1%
Central Nervous System
$56.26M-3.5%
AVAI
$38.02M+22.4%

Similar metrics at other companies

New York Times logo
NYTOther — Total revenues
$95.01M+16.3%
Biogen logo
BIIBOther — Revenue
$55.4M+88.4%
Biogen logo
BIIBOther — Total Revenue
$55.4M+88.4%
United Therapeutics logo
UTHROther — Total revenues
$5.3M+6.0%
Tradeweb Markets Inc. logo
TWOther — Total Revenue
$6.92M+90.5%
PEA
PEAKOther — Revenue

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s other — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s other — total revenue?
Medpace Holdings, Inc. (MEDP) reported other — total revenue of $93.32M in Q1 2026.
How has Medpace Holdings, Inc.'s other — total revenue changed year-over-year?
Medpace Holdings, Inc.'s other — total revenue decreased by 2.6% year-over-year, from $95.84M to $93.32M.
What is the long-term trend for Medpace Holdings, Inc.'s other — total revenue?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s other — total revenue has grown at a 11.2% compound annual growth rate (CAGR), from $267.42M to $408.55M.
What does other — total revenue mean?
The total revenue generated by the company's 'Other' business segment.
How do you interpret other — total revenue?
An increase indicates growing demand for the segment's services or successful market penetration, while a decrease may signal a loss of market share or a strategic pivot away from these specific offerings.
How does other — total revenue compare across companies?
Most clinical research organizations report revenue by service line or geography; this metric is comparable to 'Other' or 'Ancillary Services' revenue lines reported by industry competitors.